Latest Capital Raise News

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.

Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.

Audalia Resources is set to raise $450,000 through a share placement aimed at funding critical mining design and permit work for its Medcalf Project, supporting its path toward development.

Core Energy Minerals (ASX:CR3) has revealed significant rare earth element mineralisation at its Cummins Project in South Australia, highlighting broad zones of high-grade TREO with promising magnet rare earth oxide ratios and potential for in-situ recovery mining.

Cygnus Metals has reported standout high-grade assay results from its Golden Eye deposit in Quebec, with gold equivalent grades reaching 105.5g/t over 1 metre. These results reinforce the continuity of mineralisation and point to potential expansion of the Indicated Resource at the Chibougamau Copper-Gold Project.

29Metals confirms additional groundworks at Xantho Extended will push back full mining resumption, leading to lowered zinc, gold, and silver production forecasts while maintaining copper output.

Kuniko Limited has completed its Phase I diamond drilling program at the Commonwealth Gold-Silver Project, intersecting visible sulphide mineralisation in all holes and discovering a new 70m mineralised zone at Silica Hill. The company also identified a 4km conductive corridor, setting the stage for an expanded Phase II drilling campaign.

New Hope Corporation is raising A$300 million through a new convertible notes issue while simultaneously seeking to repurchase its existing A$300 million notes. The move coincides with elevated thermal coal prices amid Middle East tensions and ongoing operational guidance.

Trek Metals has wrapped up the second tranche of its $15 million placement, issuing nearly 9.7 million shares to directors at 15 cents each after shareholder approval. The move bolsters the company’s capital ahead of its drilling campaign at the Kuro manganese prospect.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing of its investigational drug PYC-001 for Autosomal Dominant Optic Atrophy from single to multiple doses, marking a key step in its clinical development.

Desert Metals Limited has launched a fully underwritten entitlement offer to raise approximately $325,000 through new options, aiming to fund ongoing exploration at its gold prospects in Côte d’Ivoire.

QEM Limited is set to acquire two past-producing critical mineral projects in Idaho, backed by a $2.645 million placement. The move aligns with US efforts to secure domestic supplies of fluorspar, tungsten, and niobium amid global supply chain vulnerabilities.